Member Info for Timster

The massive announcement that they'll be discussing at the webinar later must be this afternoon.

Hang on LDA! Thought you were watching celebrity chase?? Or have you got the betamax recorder setup for that?

It's out of hours so no live SP crashing as is standard

It's the standard poster explainer. That's all they'll be talking about.

They might choose to answers some of the finance questions when they see that's all that's being asked.

But no way they can talk about partners or deals as that would be inside info.

Is this linked to a maccyD sauce?

Something has awoken the 3 amigos

FFS, it says what it's for in the RNS:

will focus on the Company's recent data presentations on its proprietary pre|CISION® candidates FAP-Dox (AVA6000) and FAP-EXd (AVA6103) at the American Association for Cancer Research (AACR) Annual Meeting in Chicago, USA.

If you're expecting anything different I think you'll be disappointed.

Absolutely, could be a desperate attempt to attract new investors because no one's interested because of the terrible half life.

I've invoiced eggy 20p for this post.

"will focus on the Company's recent data presentations on its proprietary pre|CISION® candidates FAP-Dox (AVA6000) and FAP-EXd (AVA6103) at the American Association for Cancer Research (AACR)"

It'll be what it says! Then a Q&A of carefully hand picked "easy" questions.

One day there might be a midday RNS about a take over. We might break 35p then.

Come on LDA you can actually ask the right people for an update rather than asking on here!

They'll ignore you just the same though

Definitely planned to tie in with massive announcement just like the year end, just like AACR, just like AGM.

Might be an idea to filter the trolling twats, no loss you know exactly what will be behind the green box.

Especially if there's another 18 months of it.

Have you borrowed LDA's calender?

Like you though CJ I can wait and all evidence points to pre|CISION being remarkably good. Not just at targeting highly toxic drugs direct to tumours but also with the extra benefit of being able to tweak half life of existing drugs. In the case of AVA6103 by from 9 hours for conventional exatecan to 60 hours.

As bv said Hurstbot the headline you are quoting is from June 2024

Did you mean this one from April

https://www.fiercebiotech.com/biotech/tempus-ai-line-200m-astrazeneca-pathos-deal-develop-cancer-model

Either way it makes feck all difference to Avacta's strategic collaboration with tempusAI

OPEN PRICE MONDAY BV?

I'm saying 33 p and my target price is now £203 ex china with the Avacta Tempus buyout.

Great story which would land the CEO in court 😁

They definitely aren't selling due to massive news.

Now we have no way of knowing they might be 😃

I was only thinking yesterday how nice it is that the 3 amigos are on holiday together. Then the green boxes appear 😞

They are being held back to include a massive announcement.

The AGM will also be organised to coincide with a massive announcement as per every year.

Thank you.